Cronos Group Inc. (CRON, Financial) experienced a significant stock price increase of 5.08%, reaching $1.97 per share with a trading volume of 1.14 million shares. The stock's turnover rate was 0.30%, and it showed a volatility of 5.35%. Recent financial reports indicate revenue of $34.26 million, net income of $8.35 million, and earnings per share of $0.02. The gross profit stood at $2.51 million, with a price-to-earnings ratio of -16.29.
Among five rating institutions, 40% recommend buying, 40% suggest holding, and 20% advise selling. The broader pharmaceutical industry, where Cronos operates, saw a rise of 0.24%. Notably, related stocks like Sunshine Biopharma and Bioage Labs showed significant gains, while others like Painreform Ltd. and Quantum Biopharma Ltd. were active.
Cronos Group, based in Toronto, Canada, grows and sells medical and recreational cannabis under brands like Peace Naturals, Cove, and Spinach, primarily exporting to Israel and potentially expanding in the U.S.
